Health Canada Approves TLANDO Capsules for Testosterone Therapy
What happened
Health Canada approved TLANDO capsules, an oral testosterone undecanoate treatment, for adult males. This approval covers testosterone replacement therapy for conditions associated with male hypogonadism. Lipocine Inc. announced the approval, noting that Verity Pharmaceuticals Inc. holds exclusive commercial rights to TLANDO in North America. Verity Pharma plans to launch and commercialize the product in the Canadian market by the end of 2026.
From tickerreport.com
Why it matters
The approval is described as an important step in expanding TLANDO's geographic reach and validating its partnered commercial strategy. In Canada, over 700,000 testosterone replacement therapy prescriptions are written annually, with about 50% of patients covered by private insurance.
Health Canada regulates the approval of generic pharmaceuticals, allowing market entry following patent expiration.
From tickerreport.com
Who's involved
- Health CanadaGranted the regulatory approval for TLANDO capsules.
- Government of CanadaHealth Canada functions as a mandated department of the Government of Canada.
Keep exploring
The entities involved
-
Health Canada
Department of the Canadian Government that oversees public health